Literature DB >> 21424892

[Disease management guidelines in dermatology: implementation, potentials and limitations exemplified by the guidelines for the management of hand eczema].

B Emmert1, E Hallier, M P Schön, S Emmert.   

Abstract

In Germany, the "Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften" (AWMF; consortium of scientific medical societies) constitutes the umbrella organisation to conceive, evaluate, and release guidelines. There are 3 stages of development (S1-S3) according to the evidence level and the process of consensus finding. Currently, 59 dermatologic guidelines have been published under the auspices of the Deutsche Dermatologische Gesellschaft (German Dermatological Society). The guideline for the management of hand dermatitis (AWMF-Register-No: 013/053) is an instructive recent example. This guideline clearly demonstrates the benefits of guidelines, i.e. standardized definition of heterogeneous diseases and disease severity as well as standardized therapy algorithms. This is especially important in diseases difficult-to-treat like chronic hand dermatitis. The effective implementation of guidelines with early incorporation of new therapies, for example alitretinoin in the therapy of hand dermatitis, can considerably improve the quality of life of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21424892     DOI: 10.1007/s00105-011-2128-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  6 in total

1.  Alitretinoin as a potential advance in the management of severe chronic hand eczema.

Authors:  John R Ingram; Jonathan M Batchelor; Hywel C Williams
Journal:  Arch Dermatol       Date:  2009-03

2.  Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30.

Authors:  Thomas L Diepgen; Peter Elsner; Sibylle Schliemann; Manigé Fartasch; Arno Köllner; Christoph Skudlik; Swen M John; Margitta Worm
Journal:  J Dtsch Dermatol Ges       Date:  2009-05       Impact factor: 5.584

Review 3.  [Classification, trigger factors and course of chronic hand eczema].

Authors:  Thomas Werfel
Journal:  MMW Fortschr Med       Date:  2009-05-07

4.  Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective.

Authors:  Patricia R Blank; Armin A Blank; Thomas D Szucs
Journal:  BMC Dermatol       Date:  2010-06-25

5.  Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.

Authors:  T Ruzicka; C W Lynde; G B E Jemec; T Diepgen; J Berth-Jones; P J Coenraads; A Kaszuba; R Bissonnette; E Varjonen; P Holló; F Cambazard; M Lahfa; P Elsner; F Nyberg; A Svensson; T C Brown; M Harsch; J Maares
Journal:  Br J Dermatol       Date:  2008-02-21       Impact factor: 9.302

6.  Hand eczema is common and multifactorial.

Authors:  Pieter-Jan Coenraads
Journal:  J Invest Dermatol       Date:  2007-07       Impact factor: 8.551

  6 in total
  1 in total

1.  Palmoplantar Keratoderma: A Molecular Genetic Analysis of Family Cases.

Authors:  Olga Shchagina; Valeriy Fedotov; Tatiana Markova; Olga Shatokhina; Oksana Ryzhkova; Tatiana Fedotova; Aleksander Polyakov
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.